Corcept Therapeutics Incorporated (CORT) Financials

CORT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 814.9 million 176.9 million
Dec. 31, 2025 836.7 million 188.8 million
Sept. 30, 2025 823.6 million 191.7 million
June 30, 2025 801.7 million 165.9 million

CORT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -17.0 million 23.0 million
Dec. 31, 2025 38.4 million -63.7 million
Sept. 30, 2025 54.5 million 22.9 million
June 30, 2025 43.9 million 19.0 million

CORT Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 -31.8 million
Dec. 31, 2025 98.2 million
Sept. 30, 2025 19.4 million
June 30, 2025 35.1 million

CORT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 338.2 million 8.0 million 9.6 million
Dec. 31, 2025 372.2 million 5.0 million 6.1 million
Sept. 30, 2025 421.7 million - 5.3 million
June 30, 2025 342.2 million - 5.6 million

CORT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 104.4 million
Dec. 31, 2025 119.9 million
Sept. 30, 2025 119.4 million
June 30, 2025 120.5 million

CORT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 201000 66.3 million 145.4 million -
Dec. 31, 2025 50000 64.9 million 130.2 million -
Sept. 30, 2025 - 68.8 million 124.0 million -
June 30, 2025 57000 60.5 million 103.9 million -

CORT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 164.9 million 2.9 million
Dec. 31, 2025 202.1 million 2.5 million
Sept. 30, 2025 207.6 million 4.6 million
June 30, 2025 194.4 million 3.4 million

CORT

Price: $82.75

52 week price:
28.66
91.00

Earnings Per Share: 0.35 USD

P/E Ratio: 149

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 611800

Ebitda: 13.7 million

Market Capitalization: 7.8 billion

Links: